Mi Hye Oh

Suggest Changes
  • Citations Per Year
Learn More
Gefitnib is an oral agent of epidermal growth factor receptor tyrosine kinase inhibitor, and it has a certain efficacy against non-small cell lung cancer. There are some reports that the non-small(More)
  • 1